Clinical Trial Update: Predictive and Diagnostic Value of Tau and Beta-amyloid Markers in the Dementia of Parkinson's Disease [EARLY_Phase 1]

View source ↗

Summary

An early-phase study evaluating whether tau and beta-amyloid biomarkers can predict and diagnose dementia in Parkinson's disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease
• Parkinson Disease with Dementia

Snippet

Sponsor: Fundacion Clinic per a la Recerca Biomédica | Conditions: Parkinson's Disease, Parkinson-Dementia Syndrome | EARLY_Phase 1 | Status: COMPLETED